SHWARTZMAN PHENOMENON MECHANISM: NEWER CONCEPTS.  INHIBITON BY ANTIBRADYKININ AND ANTISEROTONIN COMPOUNDS.
D000632:Aminopyrine; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000813:Anilides; D000818:Animals; D058633:Antipyretics; D001920:Bradykinin; D004731:Endotoxins; D007793:Lagomorpha; D008070:Lipopolysaccharides; D010336:Pathology; D010600:Pharmacology; D011511:Proteus; D011817:Rabbits; D012106:Research; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D012790:Shwartzman Phenomenon
D000632:Aminopyrine; D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D000813:Anilides; D058633:Antipyretics; D001920:Bradykinin; D004731:Endotoxins; D008070:Lipopolysaccharides; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors
AMINOPYRINE; ANALGESICS AND ANTIPYRETICS; ANILIDES; BRADYKININ; ENDOTOXINS; EXPERIMENTAL LAB STUDY; LIPOPOLYSACCHARIDES; PATHOLOGY; PHARMACOLOGY; PROTEUS; RABBITS; SEROTONIN; SEROTONIN INHIBITORS; SHWARTZMAN PHENOMENON